CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

Curia’s global API aseptic processing manufacturing network has served a broad portfolio of customers worldwide for more than 20 years. This investment positions the company to support increasingly ...

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...

Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective ...

Picking a date for a press conference in Puerto Rico in the middle of hurricane season can be risky business. | Eli Lilly has ...

Cambrex will invest $120M to expand U.S. drug manufacturing, boosting API capacity at its Iowa site and adding jobs amid ...

Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical API Manufacturing Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering. This ...

Government regulations that favor API development and changes in geopolitical conditions are driving market expansion. The expansion is due to advancements in manufacturing active pharmaceutical ...

VAI means objectionable conditions or practices were found, but the regulator is not prepared to take or recommend any administrative or regulatory action.

MARLBOROUGH, Mass., Nov. 30, 2018 /PRNewswire/ — API Technologies Corp. (“API”), a leading provider of high performance RF and microwave signal conditioning and electromagnetic spectrum management ...